Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €22.08 EUR
Change Today +0.397 / 1.83%
Volume 0.0
GM0N On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 2:07 AM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

globus medical inc - a (GM0N) Snapshot

Open
€22.11
Previous Close
€21.69
Day High
€22.11
Day Low
€22.08
52 Week High
08/3/15 - €25.49
52 Week Low
09/1/14 - €13.76
Market Cap
2.1B
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
71.2M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for GLOBUS MEDICAL INC - A (GM0N)

globus medical inc - a (GM0N) Related Businessweek News

No Related Businessweek News Found

globus medical inc - a (GM0N) Details

Globus Medical, Inc., a medical device company, focuses on the design, development, and commercialization of musculoskeletal implants that promote healing in patients with spine disorders. It offers products that address an array of spinal pathologies, anatomies, and surgical approaches. The company provides fusion products that are used in cervical, thoracolumbar, sacral, and interbody/corpectomy fusion procedures to treat degenerative, deformity, tumor, and trauma conditions. It also offers disruptive technology products that provide material improvements to fusion procedures, such as minimally invasive surgical techniques, as well as new treatment alternatives, which include motion preservation technologies, such as dynamic stabilization, total disc replacement and interspinous process spacer products, and advanced biomaterials technologies; and interventional pain management solutions comprising treatments for vertebral compression fractures. The company has received pre-market approval for SECURE-C Cervical Artificial Disc; and conducting other clinical trials for ACADIA Facet Replacement System, a motion preserving anatomic reconstruction of the facet joint intended for the treatment of spinal stenosis, as well as TRIUMPH Lumbar Disc, a motion preserving disc replacement inserted obliquely into the disc space from a posterolateral approach to address posterior spinal pathology and maintain important anterior anatomical structures. It also offers human tissue products, such as bone allografts, biomaterials, and soft tissue products for spine, orthopedics, sports medicine, dental, and wound care markets. The company sells its implants and related disposables primarily to hospitals through sales representatives and independent distributors in the United States and internationally. Globus Medical, Inc. was founded in 2003 and is headquartered in Audubon, Pennsylvania.

900 Employees
Last Reported Date: 02/26/15
Founded in 2003

globus medical inc - a (GM0N) Top Compensated Officers

Co-Founder, Chairman, Chief Executive Officer...
Total Annual Compensation: $405.3K
President, Chief Operating Officer, Director ...
Total Annual Compensation: $337.8K
Co-Founder, Senior Vice President of Operatio...
Total Annual Compensation: $234.7K
Executive Vice President of U.S. Sales
Total Annual Compensation: $309.3K
Compensation as of Fiscal Year 2014.

globus medical inc - a (GM0N) Key Developments

Globus Medical, Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015; Increases Earnings Guidance for the Year 2015

Globus Medical, Inc. announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company reported net income of $24.05 million or $0.25 per diluted share on sales of $133.6 million compared to net income of $20.6 million or $0.22 per diluted share on sales of $113.6 million reported in the same period last year. Operating income was $37.0 million against $31.55 million reported last year. Income before income taxes was $37.5 million against $31.9 million reported last year. EBITDA was $43.1 million against $37.1 million reported last year. Adjusted EBITDA was $46.7 million against $40.15 million reported last year. Non-GAAP net income was $24.3 million or $0.25 per diluted share against $21.5 million or $0.23 per diluted share reported last year. For the six months, the company reported net income of $48.7 million or $0.51 per diluted share on sales of $265.2 million compared to net income of $41.8 million or $0.44 per diluted share on sales of $227.8 million reported in the same period last year. Operating income was $75.55 million against $63.8 million reported last year. Income before income taxes was $75.6 million against $64.4 million reported last year. Net cash provided by operating activities was $47.8 million against $41.6 million reported last year. Purchases of property and equipment was $25.1 million against $12.2 million reported last year. EBITDA was $86.7 million against $74.65 million reported last year. Adjusted EBITDA was $93.1 million against $82.2 million reported last year. Non-GAAP net income was $49 million or $0.51 per diluted share against $44.3 million or $0.46 per diluted share reported last year. The company increased guidance on sales by $10 million to $524 million and earnings per share by $0.02 to $1.04.

Globus Medical, Inc. to Report Q2, 2015 Results on Jul 30, 2015

Globus Medical, Inc. announced that they will report Q2, 2015 results at 5:30 PM, Eastern Daylight on Jul 30, 2015

Globus Medical, Inc., Q2 2015 Earnings Call, Jul 30, 2015

Globus Medical, Inc., Q2 2015 Earnings Call, Jul 30, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GM0N:GR €22.08 EUR +0.397

GM0N Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Integra LifeSciences Holdings Corp $60.79 USD +0.25
K2M Group Holdings Inc $21.65 USD +0.15
LDR Holding Corp $38.67 USD -0.27
NuVasive Inc $53.75 USD +1.00
Orthofix International NV $38.08 USD +0.70
View Industry Companies
 

Industry Analysis

GM0N

Industry Average

Valuation GM0N Industry Range
Price/Earnings 23.8x
Price/Sales 4.7x
Price/Book 3.7x
Price/Cash Flow 23.7x
TEV/Sales 4.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GLOBUS MEDICAL INC - A, please visit www.globusmedical.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.